Harvey Investment Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.6M | Sell |
9,675
-100
| -1% | -$102K | 1.26% | 25 |
|
|
2026
Q1 | $8.99M | Sell |
9,775
-988
| -9% | -$1M | 0.99% | 28 |
|
|
2025
Q4 | $11.6M | Sell |
10,763
-12
| -0.1% | -$11.5K | 1.23% | 26 |
|
|
2025
Q3 | $8.22M | Hold |
10,775
| – | – | 0.88% | 30 |
|
|
2025
Q2 | $8.4M | Sell |
10,775
-348
| -3% | -$270K | 0.92% | 31 |
|
|
2025
Q1 | $9.19M | Hold |
11,123
| – | – | 1.02% | 29 |
|
|
2024
Q4 | $8.59M | Sell |
11,123
-42
| -0.4% | -$34.8K | 0.99% | 30 |
|
|
2024
Q3 | $9.89M | Sell |
11,165
-470
| -4% | -$423K | 1.12% | 27 |
|
|
2024
Q2 | $10.5M | Sell |
11,635
-430
| -4% | -$344K | 1.26% | 26 |
|
|
2024
Q1 | $9.39M | Sell |
12,065
-280
| -2% | -$199K | 1.06% | 29 |
|
|
2023
Q4 | $7.2M | Sell |
12,345
-99
| -0.8% | -$57.8K | 0.87% | 30 |
|
|
2023
Q3 | $6.68M | Hold |
12,444
| – | – | 0.87% | 32 |
|
|
2023
Q2 | $5.84M | Sell |
12,444
-1,211
| -9% | -$508K | 0.76% | 34 |
|
|
2023
Q1 | $4.69M | Sell |
13,655
-300
| -2% | -$101K | 0.58% | 38 |
|
|
2022
Q4 | $5.11M | Hold |
13,955
| – | – | 0.66% | 36 |
|
|
2022
Q3 | $4.51M | Hold |
13,955
| – | – | 0.65% | 37 |
|
|
2022
Q2 | $4.53M | Sell |
13,955
-700
| -5% | -$210K | 0.64% | 39 |
|
|
2022
Q1 | $4.2M | Hold |
14,655
| – | – | 0.51% | 41 |
|
|
2021
Q4 | $4.05M | Hold |
14,655
| – | – | 0.47% | 43 |
|
|
2021
Q3 | $3.39M | Hold |
14,655
| – | – | 0.44% | 43 |
|
|
2021
Q2 | $3.36M | Hold |
14,655
| – | – | 0.44% | 42 |
|
|
2021
Q1 | $2.74M | Hold |
14,655
| – | – | 0.39% | 42 |
|
|
2020
Q4 | $2.47M | Hold |
14,655
| – | – | 0.35% | 46 |
|
|
2020
Q3 | $2.17M | Hold |
14,655
| – | – | 0.34% | 46 |
|
|
2020
Q2 | $2.41M | Hold |
14,655
| – | – | 0.41% | 45 |
|
|
2020
Q1 | $2.03M | Hold |
14,655
| – | – | 0.4% | 49 |
|
|
2019
Q4 | $1.93M | Hold |
14,655
| – | – | 0.3% | 49 |
|
|
2019
Q3 | $1.64M | Hold |
14,655
| – | – | 0.27% | 50 |
|
|
2019
Q2 | $1.62M | Hold |
14,655
| – | – | 0.27% | 49 |
|
|
2019
Q1 | $1.9M | Hold |
14,655
| – | – | 0.33% | 47 |
|
|
2018
Q4 | $1.7M | Hold |
14,655
| – | – | 0.33% | 48 |
|
|
2018
Q3 | $1.57M | Hold |
14,655
| – | – | 0.27% | 48 |
|
|
2018
Q2 | $1.25M | Hold |
14,655
| – | – | 0.23% | 54 |
|
|
2018
Q1 | $1.13M | Buy |
14,655
+99
| +0.7% | +$7.97K | 0.21% | 57 |
|
|
2017
Q4 | $1.23M | Hold |
14,556
| – | – | 0.22% | 54 |
|
|
2017
Q3 | $1.25M | Hold |
14,556
| – | – | 0.25% | 52 |
|
|
2017
Q2 | $1.2M | Hold |
14,556
| – | – | 0.24% | 52 |
|
|
2017
Q1 | $1.22M | Buy |
14,556
+166
| +1% | +$13.3K | 0.25% | 51 |
|
|
2016
Q4 | $1.06M | Hold |
14,390
| – | – | 0.22% | 54 |
|
|
2016
Q3 | $1.16M | Hold |
14,390
| – | – | 0.25% | 51 |
|
|
2016
Q2 | $1.13M | Sell |
14,390
-500
| -3% | -$37.6K | 0.25% | 53 |
|
|
2016
Q1 | $1.07M | Sell |
14,890
-1,500
| -9% | -$113K | 0.24% | 52 |
|
|
2015
Q4 | $1.38M | Hold |
16,390
| – | – | 0.32% | 51 |
|
|
2015
Q3 | $1.37M | Hold |
16,390
| – | – | 0.33% | 49 |
|
|
2015
Q2 | $1.37M | Hold |
16,390
| – | – | 0.32% | 51 |
|
|
2015
Q1 | $1.19M | Hold |
16,390
| – | – | 0.28% | 52 |
|
|
2014
Q4 | $1.13M | Hold |
16,390
| – | – | 0.26% | 52 |
|
|
2014
Q3 | $1.06M | Hold |
16,390
| – | – | 0.27% | 53 |
|
|
2014
Q2 | $1.02M | Sell |
16,390
-1,000
| -6% | -$59.7K | 0.25% | 53 |
|
|
2014
Q1 | $1.02M | Hold |
17,390
| – | – | 0.26% | 50 |
|
|
2013
Q4 | $887K | Hold |
17,390
| – | – | 0.24% | 56 |
|
|
2013
Q3 | $875K | Hold |
17,390
| – | – | 0.25% | 55 |
|
|
2013
Q2 | $854K | Buy |
+17,390
| New | +$946K | 0.26% | 55 |
|
Other funds holding LLY
SC
ONB
GIM
Harvey Investment Company's LLY Position: Q2 2026 in Review
Harvey Investment Company reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $102K and leaving 9,675 shares worth $11.6M. The position accounts for 1.26% of the portfolio, ranked #25.
Harvey Investment Company first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Harvey Investment Company held 9,675 shares of Eli Lilly worth $11.6M as of Q2 2026.
- Harvey Investment Company sold 100 Eli Lilly shares in Q2 2026, an estimated $102K.
- Eli Lilly made up 1.26% of Harvey Investment Company's portfolio in Q2 2026, its #25 holding.
- Harvey Investment Company first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Harvey Investment Company's 13F filing for Q2 2026, filed 22 Jul 2026.